Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Pik3caem1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Pik3caem1/Cya

Common Name
Pik3ca-KO
Product ID
S-KO-03651
Backgroud
C57BL/6JCya
Strain ID
KOCMP-18706-Pik3ca-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Pik3ca-KO Mouse (Catalog S-KO-03651) were purchased from Cyagen.”
KO Models
mTOR signaling pathway
AMPK signaling pathway
ErbB signaling pathway
JAK-STAT signaling pathway
PI3K-Akt signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
mTOR signaling pathway
AMPK signaling pathway
ErbB signaling pathway
JAK-STAT signaling pathway
PI3K-Akt signaling pathway
Basic Information
Strain Name
Pik3ca-KO
Strain ID
KOCMP-18706-Pik3ca-B6J-VA
Gene Name
Pik3ca
Product ID
S-KO-03651
Gene Alias
p110, caPI3K, p110alpha, 6330412C24Rik
Background
C57BL/6JCya
Gene Full Name
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
Modification
Conventional knockout
NCBI ID
18706 (Mouse)
Phenotype
MGI:1206581
Chromosome
Chr 3 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000108243
NCBI Transcript ID
NM_008839
Target Region
Exon 5~6
Size of Effective Region
~1.8 kb
Overview of Gene Research
PIK3CA, encoding the catalytic subunit p110α of Class IA Phosphatidylinositol 3-kinases (PI3K), is crucial in regulating cell survival, growth, cell cycle, and metabolism. It functions via the activation of the mTOR1-AKT pathway, a key signaling cascade involved in numerous biological processes [1,2].

Gain-of-function mutations in PIK3CA have been linked to a variety of disorders. Somatic activating mutations in PIK3CA are associated with vascular overgrowth syndromes, such as Klippel-Trenaunay syndrome, within the PIK3CA-related overgrowth spectrum (PROS). These mutations can lead to complications like thromboembolic events and orthopedic issues due to asymmetric overgrowth [1]. In cancer, PIK3CA mutations are prevalent, associated with resistance to first-line treatment and low survival rates in malignancies like colorectal cancer. There is evidence that PIK3CA-mutated colorectal cancer patients may benefit from aspirin treatment, though the exact mechanisms remain unclear [2]. PIK3CA mutations in solid malignancies are associated with poor prognosis, and inhibitors of the PI3K/AKT/mTOR pathway are being investigated as potential therapies [3]. In endometrial cancer, PIK3CA mutations seem to negatively influence survival outcomes, especially in low-grade tumors [4].

In conclusion, PIK3CA is essential in regulating key cellular functions through the mTOR1-AKT pathway. Research on PIK3CA-related disorders, especially those involving its mutations, has significant implications for understanding the pathogenesis of vascular overgrowth syndromes and various cancers. The study of PIK3CA provides potential therapeutic targets for these disease areas, highlighting the importance of further functional studies and in vivo research models such as KO/CKO mouse models to better elucidate its role in health and disease.

References:
1. Hughes, Meagan, Hao, Michelle, Luu, Minnelly. . PIK3CA vascular overgrowth syndromes: an update. In Current opinion in pediatrics, 32, 539-546. doi:10.1097/MOP.0000000000000923. https://pubmed.ncbi.nlm.nih.gov/32692051/
2. Hall, Daniella C N, Benndorf, Ralf A. 2022. Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited. In Cellular and molecular life sciences : CMLS, 79, 393. doi:10.1007/s00018-022-04430-y. https://pubmed.ncbi.nlm.nih.gov/35780223/
3. Willis, Owen, Choucair, Khalil, Alloghbi, Abdurahman, Dworkin, Lance, Nemunaitis, John. 2020. PIK3CA gene aberrancy and role in targeted therapy of solid malignancies. In Cancer gene therapy, 27, 634-644. doi:10.1038/s41417-020-0164-0. https://pubmed.ncbi.nlm.nih.gov/31988478/
4. Bredin, Hanna K, Krakstad, Camilla, Hoivik, Erling A. 2023. PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. In PloS one, 18, e0283203. doi:10.1371/journal.pone.0283203. https://pubmed.ncbi.nlm.nih.gov/36943861/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research